DNA Controversy

To the Editors of The Crimson:

So that your readers may be properly and fairly informed regarding the recombinant DNA (gene transplant) research controversy, it is important that your newspaper make available to them the following pertinent information.

When scientists are described to newspaper readers as Nobel Laureates affiliated with a prestigious institution, their views are received as those of honored, impartial scientists. It is therefore essential for realistic evaluation of such views that readers know of the commercial connections of Dr. David Baltimore and Dr. Salvador Luria: both are listed as consultants in the brochure of Collaborative research, of Waltham, a company that manufactures products employed in the assay of restriction enzymes used in recombinant DNA research. Francine Robinson Simring, Chairman   Committee for Genetics